~~<i id='693B47863D'><strike id='693B47863D'><tt id='693B47863D'><pre id='693B47863D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

author：comprehensive 2025-08-12 08:27:42 - browse：869

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Plane’s emergency slide plummets from sky, hits Chicago home

leisure time

hotspot

focus

hotspot

TruckstransportchromiumorenearamineatKaliapanivillageinJajpurdistrict,Odisha,IndiaonThursday,July6,2

WSS

White House announces new plan to address the growing threat of xylazine in overdose crisis

Create a giant ice tray with this foil pan hack to keep food cold this summer

Create a giant ice tray with this foil pan hack to keep food cold this summer

Biden declares emergency in flood

Plane’s emergency slide plummets from sky, hits Chicago home

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

leisure time

leisure time

leisure time

Hepatitis C has a cure — but many Americans still lack access to it

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

Alkermes shareholders re

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

Duchenne breakthrough therapy leaves behind pioneering families

Pandemic and All Hazards Preparedness Act needs lean update

BioMarin wins approval for gene therapy to treat hemophilia A

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Affirmative action in medical school literally saved lives

Biden’s NIH nominee is languishing in Congress

hotspot

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

White House announces new plan to address the growing threat of xylazine in overdose crisis

Pandemic and All Hazards Preparedness Act needs lean update

Trump got a 'target letter.' What is one and what does it mean?

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Home health providers sue Medicare over payment cuts

hotspot

hotspot

focus

hotspot